Bio-Gene Technology Ltd (BGT) - Total Liabilities

Latest as of December 2025: AU$307.71K AUD ≈ $217.72K USD

Based on the latest financial reports, Bio-Gene Technology Ltd (BGT) has total liabilities worth AU$307.71K AUD (≈ $217.72K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Bio-Gene Technology Ltd - Total Liabilities Trend (2014–2025)

This chart illustrates how Bio-Gene Technology Ltd's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Bio-Gene Technology Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

Bio-Gene Technology Ltd Competitors by Total Liabilities

The table below lists competitors of Bio-Gene Technology Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
K9 Gold Corp V:KNC	Canada	CA$110.11K
Sentral Mitra Informatika Tbk PT JK:LUCK	Indonesia	Rp22.81 Billion
ASN Broker Public Company Limited BK:ASN	Thailand	฿231.16 Million
Dunedin Income Growth Investment Trust PLC LSE:DIG	UK	GBX50.01 Million
Collplant Biotechnologies Ltd NASDAQ:CLGN	USA	$4.78 Million
Hydrocarbon Dynamics Ltd AU:HCD	Australia	AU$436.69K
Golden Sun Education Group Ltd NASDAQ:GSUN	USA	$15.13 Million
Megaron SA WAR:MEG	Poland	zł10.27 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Bio-Gene Technology Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Bio-Gene Technology Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.31	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.26	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.21	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bio-Gene Technology Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bio-Gene Technology Ltd (2014–2025)

The table below shows the annual total liabilities of Bio-Gene Technology Ltd from 2014 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$522.98K ≈ $370.04K	+41.94%
2024-06-30	AU$368.45K ≈ $260.70K	-39.98%
2023-06-30	AU$613.88K ≈ $434.36K	-40.67%
2022-06-30	AU$1.03 Million ≈ $732.10K	+37.12%
2021-06-30	AU$754.57K ≈ $533.91K	+33.01%
2020-06-30	AU$567.29K ≈ $401.39K	-7.55%
2019-06-30	AU$613.61K ≈ $434.17K	-19.22%
2018-06-30	AU$759.59K ≈ $537.46K	+103.13%
2017-06-30	AU$373.94K ≈ $264.58K	-2.37%
2016-06-30	AU$383.00K ≈ $271.00K	+40004.71%
2014-06-30	AU$955.00 ≈ $675.72	--

About Bio-Gene Technology Ltd

AU:BGT Australia Biotechnology

Market Cap

$4.32 Million

AU$6.10 Million AUD

Market Cap Rank

#28831 Global

#1590 in Australia

Share Price

AU$0.02

Change (1 day)

+0.00%

52-Week Range

AU$0.02 - AU$0.04

All Time High

AU$0.34